Your browser is no longer supported. Please, upgrade your browser.
Settings
SLP Simulations Plus, Inc. daily Stock Chart
SLP [NASD]
Simulations Plus, Inc.
Index- P/E74.13 EPS (ttm)0.48 Insider Own29.00% Shs Outstand17.51M Perf Week5.01%
Market Cap616.53M Forward P/E- EPS next Y- Insider Trans-1.31% Shs Float12.33M Perf Month1.82%
Income8.60M PEG3.71 EPS next Q0.12 Inst Own48.80% Short Float7.98% Perf Quarter-4.89%
Sales34.00M P/S18.13 EPS this Y14.20% Inst Trans9.58% Short Ratio8.40 Perf Half Y38.13%
Book/sh2.15 P/B16.38 EPS next Y- ROA19.50% Target Price37.00 Perf Year73.45%
Cash/sh0.65 P/C54.08 EPS next 5Y20.00% ROE24.60% 52W Range17.18 - 41.95 Perf YTD76.93%
Dividend0.24 P/FCF84.46 EPS past 5Y20.90% ROI23.00% 52W High-15.02% Beta-0.35
Dividend %0.68% Quick Ratio4.40 Sales past 5Y24.30% Gross Margin73.40% 52W Low107.51% ATR1.16
Employees107 Current Ratio4.40 Sales Q/Q19.40% Oper. Margin31.10% RSI (14)57.41 Volatility4.24% 3.24%
OptionableYes Debt/Eq0.00 EPS Q/Q51.30% Profit Margin25.30% Rel Volume0.56 Prev Close35.21
ShortableYes LT Debt/Eq0.00 EarningsNov 13 AMC Payout36.70% Avg Volume117.14K Price35.65
Recom2.00 SMA204.89% SMA503.51% SMA20024.01% Volume59,800 Change1.25%
Nov-14-19 08:30AM  Simulations Plus Partners with Large Pharmaceutical Company to Enhance the Mechanistic Oral Absorption (ACAT) Model in GastroPlus Business Wire +5.39%
Nov-13-19 05:25PM  Simulations Plus (SLP) Beats Q4 Earnings and Revenue Estimates Zacks
04:05PM  Simulations Plus Reports FY2019 and Fourth Quarter FY2019 Financial Results Business Wire
Nov-06-19 10:30AM  Simulations Plus (SLP) Earnings Expected to Grow: What to Know Ahead of Q4 Release Zacks
08:30AM  Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2019 Earnings Release and Conference Call Business Wire
Oct-30-19 08:22PM  Hedge Funds Have Never Been This Bullish On Simulations Plus, Inc. (SLP) Insider Monkey
Oct-29-19 08:30AM  Simulations Plus to Support Development of Radiation Countermeasure via New QSP Platform (RADAsym) and Pharmacometrics Modeling Business Wire
Oct-17-19 08:30AM  Simulations Plus Partners with Large Pharmaceutical Company to Develop the Virtual Bioequivalence Trial Simulator Module Business Wire
Oct-15-19 11:32AM  How Many Simulations Plus, Inc. (NASDAQ:SLP) Shares Have Insiders Sold, In The Last Year? Simply Wall St.
Oct-14-19 02:30PM  Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share Business Wire
Oct-02-19 08:30AM  Simulations Plus Announces Leadership Changes at Cognigen Business Wire
Sep-26-19 02:31PM  Three Consumer ETFs Near Highs, But Is Good Mood Fading? Investor's Business Daily
Sep-17-19 11:18AM  Despite Its High P/E Ratio, Is Simulations Plus, Inc. (NASDAQ:SLP) Still Undervalued? Simply Wall St.
Sep-12-19 09:16AM  Simulations Plus Sees Hammer Chart Pattern: Time to Buy? Zacks
Sep-11-19 07:00AM  Bear of the Day: Autodesk (ADSK) Zacks
Sep-06-19 09:30AM  Has Simulations Plus (SLP) Outpaced Other Computer and Technology Stocks This Year? Zacks
Sep-04-19 08:30AM  Simulations Plus Partners with Clinical-Stage Biotech Company to Develop Novel Dosing Models Business Wire
Aug-21-19 11:47AM  Why You Should Like Simulations Plus, Inc.s (NASDAQ:SLP) ROCE Simply Wall St.
09:30AM  Is Simulations Plus (SLP) Outperforming Other Computer and Technology Stocks This Year? Zacks
Aug-08-19 08:52PM  Why Simulations Plus Stock Soared 35.9% in July Motley Fool +5.10%
Aug-05-19 09:30AM  Has Simulations Plus (SLP) Outpaced Other Computer and Technology Stocks This Year? Zacks
Aug-02-19 05:00PM  This Is Not A Simulation: IBD Stock Of The Day Flashes Sell Signals Investor's Business Daily -11.88%
Jul-29-19 01:47PM  Top Stock Picks for Week of July 29, 2019 Zacks
Jul-22-19 07:52AM  Do Insiders Own Lots Of Shares In Simulations Plus, Inc. (NASDAQ:SLP)? Simply Wall St.
Jul-19-19 08:02AM  Simulations Plus' Shares March Higher, Can It Continue? Zacks
Jul-18-19 09:30AM  Is Simulations Plus (SLP) Outperforming Other Computer and Technology Stocks This Year? Zacks +5.00%
Jul-16-19 08:30AM  Simulations Plus Enters into New Research Collaboration Agreement with the FDA Business Wire
Jul-11-19 05:39PM  Edited Transcript of SLP earnings conference call or presentation 10-Jul-19 8:15pm GMT Thomson Reuters StreetEvents +6.40%
Jul-10-19 06:23PM  Simulations Plus Inc (SLP) Q3 2019 Earnings Call Transcript Motley Fool
05:15PM  Simulations Plus (SLP) Q3 Earnings and Revenues Beat Estimates Zacks
04:05PM  Simulations Plus Reports Third Quarter FY2019 Financial Results Business Wire
Jul-09-19 08:30AM  Simulations Plus Upgrades PKPlus Business Wire
Jul-03-19 10:30AM  Simulations Plus (SLP) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Jul-02-19 10:30AM  Simulations Plus (SLP) Earnings Expected to Grow: Should You Buy? Zacks
08:30AM  Simulations Plus Sets Date for 3rd Quarter 2019 Earnings Release and Conference Call Business Wire
Jun-29-19 09:24AM  Is Simulations Plus, Inc. (NASDAQ:SLP) A High Quality Stock To Own? Simply Wall St.
Jun-27-19 08:30AM  DILIsym Releases NAFLDsym® Version 2A Business Wire
Jun-24-19 09:15AM  Stocks Rise for Third Straight Week Zacks
Jun-18-19 08:30AM  Simulations Plus Upgrades Flagship GastroPlus Business Wire
Jun-11-19 08:30AM  Cognigen Launches KIWI Version 4.0 Business Wire
Jun-10-19 08:02AM  New Strong Buy Stocks for June 10th Zacks +6.23%
May-30-19 02:49PM  Why Fundamental Investors Might Love Simulations Plus, Inc. (NASDAQ:SLP) Simply Wall St.
May-21-19 08:30AM  PMDA Adds Licenses of GastroPlus® Business Wire
May-16-19 08:30AM  U.S. FDA Renews DILIsym Software Licenses Business Wire
May-14-19 08:30AM  Simulations Plus to Present at B. Riley FBR Investor Conference on May 22, 2019 Business Wire
May-09-19 11:09AM  Simulations Plus (NASDAQ:SLP) Shareholders Have Enjoyed A Whopping 304% Share Price Gain Simply Wall St.
May-01-19 04:15PM  Lisa LaVange, PhD, Appointed to Board of Directors of Simulations Plus Business Wire
Apr-30-19 08:30AM  FDA Purchases Bundle of ADMET Predictor® Licenses Business Wire
Apr-18-19 11:37AM  Edited Transcript of SLP earnings conference call or presentation 9-Apr-19 8:15pm GMT Thomson Reuters StreetEvents
Apr-11-19 08:30AM  Simulations Plus Releases ADMET Predictor® Version 9.5 Business Wire
Apr-09-19 08:16PM  Simulations Plus Inc (SLP) Q2 2019 Earnings Call Transcript Motley Fool
05:15PM  Simulations Plus (SLP) Q2 Earnings and Revenues Surpass Estimates Zacks
04:13PM  Simulations Plus: Fiscal 2Q Earnings Snapshot Associated Press
04:05PM  Simulations Plus Reports Record Second Quarter FY2019 Revenue Business Wire
Apr-04-19 08:57AM  The Simulations Plus (NASDAQ:SLP) Share Price Has Gained 230%, So Why Not Pay It Some Attention? Simply Wall St.
Apr-02-19 08:30AM  Simulations Plus Sets Date for 2nd Quarter 2019 Earnings Release and Conference Call Business Wire
Apr-01-19 10:30AM  Analysts Estimate Simulations Plus (SLP) to Report a Decline in Earnings: What to Look Out for Zacks
Feb-19-19 11:57AM  Has Simulations Plus, Inc. (NASDAQ:SLP) Improved Earnings Growth In Recent Times? Simply Wall St.
Feb-15-19 09:06AM  Top 4 Oil and Gas Penny Stocks for 2019 Investopedia
Jan-30-19 04:54AM  Moving Average Crossover Alert: Simulations Plus Zacks
Jan-29-19 12:51PM  Something To Consider Before Buying Simulations Plus, Inc. (NASDAQ:SLP) For The 1.2% Dividend Simply Wall St.
Jan-17-19 08:30AM  DILIsym Awarded $1.5 Million Phase II NIH Grant Business Wire
Jan-16-19 10:13AM  Edited Transcript of SLP earnings conference call or presentation 9-Jan-19 9:15pm GMT Thomson Reuters StreetEvents
Jan-15-19 08:30AM  Simulations Plus Releases DDDPlus Version 6 Business Wire
Jan-14-19 08:30AM  DILIsym Services Inc. Initiates Development of IPFsym Business Wire
Jan-10-19 08:30AM  Simulations Plus to Present at the 21st Annual Needham Growth Conference Business Wire -6.87%
Jan-09-19 07:50PM  Simulations Plus Inc (SLP) Q1 2019 Earnings Conference Call Transcript Motley Fool
05:15PM  Simulations Plus (SLP) Q1 Earnings Lag Estimates Zacks
04:11PM  Simulations Plus: Fiscal 1Q Earnings Snapshot Associated Press
04:05PM  Simulations Plus Reports First Quarter FY2019 Financial Results Business Wire
12:45PM  Should You Be Worried About Insider Transactions At Simulations Plus, Inc. (NASDAQ:SLP)? Simply Wall St.
Jan-07-19 08:30AM  DILIsym Services Inc. Releases DILIsym® Version 8A Business Wire
Jan-02-19 08:30AM  Simulations Plus to Report First Quarter Fiscal Year 2019 Financial Results Business Wire
Jan-01-19 10:30AM  Simulations Plus (SLP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Dec-28-18 08:41AM  Should You Get Rid of Simulations Plus (SLP) Now? Zacks
Dec-10-18 12:29PM  Could The Simulations Plus Inc (NASDAQ:SLP) Ownership Structure Tell Us Something Useful? Simply Wall St.
Nov-20-18 08:30AM  Simulations Plus to Present at LD Micro 11th Annual Main Event Investor Conference on December 4, 2018 Business Wire -7.28%
Nov-19-18 08:35AM  New Research Coverage Highlights Famous Dave's of America, Great Elm Capital Group, Otelco, Simulations Plus, SilverSun Technologies, Inc., and ENGlobal Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Nov-15-18 03:28PM  SIMULATIONS PLUS, INC. (SLP) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:27AM  Edited Transcript of SLP earnings conference call or presentation 14-Nov-18 9:15pm GMT Thomson Reuters StreetEvents
Nov-14-18 05:55PM  Simulations Plus (SLP) Tops Q4 Earnings and Revenue Estimates Zacks
04:50PM  Simulations Plus: Fiscal 4Q Earnings Snapshot Associated Press
04:05PM  Simulations Plus Reports FY2018 and Fourth Quarter FY2018 Financial Results Business Wire
Nov-09-18 11:17AM  Does The Data Make Simulations Plus Inc (NASDAQ:SLP) An Attractive Investment? Simply Wall St.
Nov-07-18 08:30AM  Simulations Plus to Report 4th Quarter and Fiscal Year 2018 Financial Results Business Wire
Nov-06-18 05:36PM  DILIsym Services, an SLP Company, Launches Consortium for Drug-Related Kidney Injury Business Wire
10:30AM  Simulations Plus (SLP) Q4 Earnings Preview: What's in the Cards? Zacks
Oct-22-18 03:50PM  Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share Business Wire
Oct-10-18 07:59AM  Is Simulations Plus Incs (NASDAQ:SLP) PE Ratio A Signal To Buy For Investors? Simply Wall St.
Sep-14-18 08:05AM  How Simulations Plus Inc (NASDAQ:SLP) Delivered A Better ROE Than Its Industry Simply Wall St.
Sep-12-18 08:30AM  Simulations Plus Receives New Grant Award from the FDA Business Wire
Sep-05-18 08:30AM  Simulations Plus Extends Funded Research Collaboration with the FDA Business Wire
Jul-24-18 07:00AM  Ex-Dividend Schedule: Simulations Plus Has a Dividend Yield of 1.32%; Will Trade Ex-Dividend on July 25, 2018 ACCESSWIRE
Jul-23-18 08:30AM  Simulations Plus Subsidiary DILIsym Awarded Grant for up to $1.7 Million For Model Development Business Wire
Jul-18-18 08:30AM  Simulations Plus Enters Funded Research Collaboration with Large European Consortium Business Wire
Jul-17-18 03:12PM  Edited Transcript of SLP earnings conference call or presentation 10-Jul-18 8:15pm GMT Thomson Reuters StreetEvents
Jul-11-18 12:54PM  Simulations Plus, Inc. (SLP) Q3 2018 Earnings Conference Call Transcript Motley Fool -21.71%
Jul-10-18 04:05PM  Simulations Plus: Fiscal 3Q Earnings Snapshot Associated Press
04:01PM  Simulations Plus Reports Third Quarter FY2018 Financial Results Business Wire
02:15PM  Simulations Plus, Inc. to Host Earnings Call ACCESSWIRE
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher. In addition, it offers MedChem Studio, a software tool for data mining and designing new molecules; KIWI, a cloud-based Web application to organize, process, maintain, and communicate the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; NAFLDsym, a simulation program for analyzing nonalcoholic fatty liver disease; and RENAsym for investigating and predicting drug-induced or acute kidney injury. Further, the company provides population modeling and simulation contract research services for the pharmaceutical and biotechnology industries; and clinical-pharmacology-based consulting services in support of regulatory submissions. It sells its pharmaceutical/chemistry software to pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies. The company was founded in 1996 and is headquartered in Lancaster, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KNEISEL JOHN ROBERTCFONov 12Option Exercise6.854,40030,1404,400Nov 13 05:25 PM
WOLTOSZ WALTER SDirectorOct 27Sale33.4524,000802,8005,063,918Oct 28 07:28 PM
WOLTOSZ WALTER SDirectorSep 24Sale35.8624,000860,6405,087,918Sep 25 05:46 PM
Paglia John KennethDirectorAug 06Sale37.8669026,1232,112Aug 06 03:43 PM
WOLTOSZ WALTER SDirectorMay 28Sale25.6718,500474,8955,178,083May 29 08:58 AM
WOLTOSZ WALTER SChairmanApr 26Sale22.1118,500409,0355,196,039Apr 30 05:02 PM
Ralph David L.DirectorApr 12Sale22.743,00068,22018,006Apr 15 10:16 AM
WOLTOSZ WALTER SChairman of the boardMar 27Sale20.6418,500381,8405,214,539Apr 01 03:46 PM
WOLTOSZ WALTER SChairman of the BoardJan 28Sale18.6618,500345,2105,250,912Jan 29 07:10 PM